Trials & Tribulations Why infection and immunity matter for Florida’s cancer patients February 13, 2026Vol.52 No.06By Eduardo Sotomayor
Cancer Policy Super Bowl ad by Hims & Hers features GRAIL’s Galleri MCD test February 13, 2026Vol.52 No.06By Jacquelyn Cobb and Sara Willa Ernst
Cancer Policy FDA approves labeling changes to menopausal hormone therapy products February 13, 2026Vol.52 No.06By Claire Marie Porter
Cancer Policy HHS withdraws 340B drug rebate pilot program February 13, 2026Vol.52 No.06By Sara Willa Ernst
In Brief David Gius named director of University of Cincinnati Cancer Center February 13, 2026Vol.52 No.06
In Brief Team USA’s Julie Letai competes in Milan Olympics speed skating event February 13, 2026Vol.52 No.06
In Brief “The Journey to End Cancer: From Cause to Cure” exhibit launches national tour, with MD Anderson as presenting sponsor February 13, 2026Vol.52 No.06
In Brief NAM New Voices Program for emerging STEM leaders announces 2026 cohort February 13, 2026Vol.52 No.06
In Brief Curebound adds five business leaders to board to accelerate cancer research February 13, 2026Vol.52 No.06
Clinical Roundup Advanced PET/CT imaging can improve long-term outcomes in recurrent prostate cancer, UCLA-led study finds February 13, 2026Vol.52 No.06
